Stormont-Vail HealthCare, KS: Update to credit analysis

Stormont-Vail HealthCare, KS: Update to credit analysis following upgrade - Credit Opinion – 2024/04/22 – US$ 250.00 – ...Based on audited financial statements for Stormont-Vail HealthCare for fiscal years ended September 30; projections provided by management. Investment returns normalized at 5%. Fiscal 2020 excludes $72.2 million of Medicare Accelerated Payments (MAP), fiscal 2021 excludes $70.2 million of MAP, fiscal 2022 excludes $28.9 million of MAP. Source: Moody's Ratings...

Moody's Ratings upgrades Stormont-Vail HealthCare (KS) to A1; outlook revised to stable - Rating Action – 2024/04/17 – US$ 180.00 – ...MOODY'S CREDIT RATINGS, ASSESSMENTS, OTHER OPINIONS, AND PUBLICATIONS ARE NOT INTENDED FOR USE BY RETAIL INVESTORS AND IT WOULD BE RECKLESS AND INAPPROPRIATE FOR RETAIL INVESTORS TO USE MOODY'S CREDIT RATINGS, ASSESSMENTS, OTHER OPINIONS OR PUBLICATIONS WHEN MAKING AN INVESTMENT DECISION. IF IN DOUBT YOU SHOULD CONTACT YOUR FINANCIAL OR OTHER PROFESSIONAL ADVISER. ALL INFORMATION CONTAINED HEREIN IS PROTECTED BY LAW, INCLUDING BUT NOT LIMITED TO, COPYRIGHT LAW, AND NONE OF SUCH INFORMATION MAY BE COPIED OR OTHERWISE REPRODUCED, REPACKAGED, FURTHER TRANSMITTED, TRANSFERRED, DISSEMINATED, REDISTRIBUTED OR RESOLD, OR STORED FOR SUBSEQUENT USE FOR ANY SUCH PURPOSE, IN WHOLE OR IN PART, IN ANY FORM OR MANNER OR BY ANY MEANS WHATSOEVER, BY ANY PERSON WITHOUT MOODY'S PRIOR WRITTEN CONSENT. MOODY'S CREDIT RATINGS, ASSESSMENTS, OTHER OPINIONS AND PUBLICATIONS ARE NOT INTENDED FOR USE BY ANY PERSON AS A BENCHMARK AS THAT TERM IS DEFINED FOR REGULATORY PURPOSES AND MUST NOT BE USED IN ANY WAY THAT...

Moody's assigns A2 issuer rating to Stormont-Vail HealthCare (KS); outlook positive - Rating Action – 2023/01/27 – US$ 180.00 – ...MOODY'S CREDIT RATINGS, ASSESSMENTS, OTHER OPINIONS, AND PUBLICATIONS ARE NOT INTENDED FOR USE BY RETAIL INVESTORS AND IT WOULD BE RECKLESS AND INAPPROPRIATE FOR RETAIL INVESTORS TO USE MOODY'S CREDIT RATINGS, ASSESSMENTS, OTHER OPINIONS OR PUBLICATIONS WHEN MAKING AN INVESTMENT DECISION. IF IN DOUBT YOU SHOULD CONTACT YOUR FINANCIAL OR OTHER PROFESSIONAL ADVISER. ALL INFORMATION CONTAINED HEREIN IS PROTECTED BY LAW, INCLUDING BUT NOT LIMITED TO, COPYRIGHT LAW, AND NONE OF SUCH INFORMATION MAY BE COPIED OR OTHERWISE REPRODUCED, REPACKAGED, FURTHER TRANSMITTED, TRANSFERRED, DISSEMINATED, REDISTRIBUTED OR RESOLD, OR STORED FOR SUBSEQUENT USE FOR ANY SUCH PURPOSE, IN WHOLE OR IN PART, IN ANY FORM OR MANNER OR BY ANY MEANS WHATSOEVER, BY ANY PERSON WITHOUT MOODY'S PRIOR WRITTEN CONSENT. MOODY'S CREDIT RATINGS, ASSESSMENTS, OTHER OPINIONS AND PUBLICATIONS ARE NOT INTENDED FOR USE BY ANY PERSON AS A BENCHMARK AS THAT TERM IS DEFINED FOR REGULATORY PURPOSES AND MUST NOT BE USED IN ANY WAY THAT...

Stormont-Vail HealthCare, KS: Update following outlook revision to positive - Credit Opinion – 2022/05/09 – US$ 250.00 – ...Stormont-Vail's (A2 positive) (SVHC) credit quality reflects expectations of further revenue growth, given the system's leading primary market share as a tertiary referral center, continued growth and investment in its large employed multi-specialty physician group and further expansion into the fast growing Manhattan, KS market. While industrywide labor shortages and pandemic related volume disruption will result in margin moderation in fiscal 2022, management expects margins to return to stronger levels thereafter. Additionally, SVHC's credit quality incorporates expectations of additional balance sheet strengthening, given manageable capital spending plans and moderate debt levels, including a materially reduced pension obligation. Offsetting considerations include the presence of an academic affiliated medical center in SVHC's primary market and a relatively modest revenue base for the rating category. Lastly, elevated labor and supply costs will constrain margins over the near-term....

Stormont-Vail HealthCare, KS: Update to analysis - Credit Opinion – 2020/03/26 – US$ 250.00 – ...Stormont-Vail HealthCare (SVHC, A2 stable) will continue to sustain strong operating performance and balance sheet metrics while management implements growth strategies. Stormont-Vail Health expects to open three ambulatory clinics in the next three years with the first expected in June 2020. Stormont-Vail Health will also continue to expand its presence in high growth Manhattan, KS, approximately 50 miles west of its flagship in Topeka, to support its recent ownership interest in a surgical hospital. The rating is further supported by Stormont-Vail Health's continued growth and investment in its large employed physician group, the Cotton O'Neil medical group, which we view as a market differentiator despite the presence of an academic medical center in its primary market. Challenges include a variance to total revenue and margin targets in 2019 due to a decline in inpatient volumes though year to date 2020 is exceeding budget. While Stormont-Vail Health's revenue base is somewhat modest,...

Stormont-Vail HealthCare, KS: Update following revision of outlook to stable - Credit Opinion – 2019/07/03 – US$ 250.00 – ...Stormont-Vail HealthCare (SVHC, A2 stable) will sustain its current operating performance with the execution of management's growth strategies. Through the system's continued growth and investment in its large physician group, the Cotton O'Neil Medical Group, Moody's expects SVHC will maintain its leading market position despite the presence of an academic medical center in its primary market. Challenges include direct competition in its primary service area by a joint venture between a for-profit enterprise and a nearby academic medical center. While balance sheet metrics will remain strong, liquidity will decline in the near term to fund capital....

Moody's assigns A2 rating to Stormont-Vail HealthCare's (KS) Series 2013J fixed rate bonds; outlook stable - New Issue – 2013/10/23 – US$ 750.00